These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


418 related items for PubMed ID: 6132540

  • 21. HI antibody response in volunteers vaccinated with live influenza A/New Jersey/76 vaccine.
    Ikić D, Smerdel S, Manhalter T, Pasini N, Delimar N.
    Dev Biol Stand; ; 39():67-71. PubMed ID: 342319
    [Abstract] [Full Text] [Related]

  • 22. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion.
    Maas R, Tacken M, van Zoelen D, Oei H.
    Vaccine; 2009 Jun 02; 27(27):3592-7. PubMed ID: 19464539
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
    Kyriakis CS, Gramer MR, Barbé F, Van Doorsselaere J, Van Reeth K.
    Vet Microbiol; 2010 Jul 29; 144(1-2):67-74. PubMed ID: 20116942
    [Abstract] [Full Text] [Related]

  • 24. Live tissue culture influenza vaccine for oral administration. I. Specific immune response to monovaccine A (H3N2) in volunteers.
    Alekseeva AK, Andzhaparidze OG, Gracheva EN, Sidorova LA, Melnikova SK.
    Acta Virol; 1979 Jan 29; 23(1):59-66. PubMed ID: 35960
    [Abstract] [Full Text] [Related]

  • 25. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J, Skocil V, Farník J, Hronovský F, Síp J.
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep 29; 30(5):287-93. PubMed ID: 6456837
    [No Abstract] [Full Text] [Related]

  • 26. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 27. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D.
    J Rheumatol; 2002 Dec 27; 29(12):2555-7. PubMed ID: 12465151
    [Abstract] [Full Text] [Related]

  • 28. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A, Potter CW, Jennings R, Nicholl JP, Langrick AF, Schild GC, Wood JM, Tyrrell DA.
    J Hyg (Lond); 1983 Jun 27; 90(3):351-9. PubMed ID: 6863909
    [Abstract] [Full Text] [Related]

  • 29. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z.
    J Med Virol; 2001 Sep 27; 65(1):178-84. PubMed ID: 11505461
    [Abstract] [Full Text] [Related]

  • 30. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 May 22; 58(19):521-4. PubMed ID: 19478718
    [Abstract] [Full Text] [Related]

  • 31. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
    Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D.
    J Infect Dis; 2006 Oct 15; 194(8):1032-9. PubMed ID: 16991077
    [Abstract] [Full Text] [Related]

  • 32. Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage.
    Song JY, Ha SH, Kee SY, Jeong HW, Cheong HJ, Kim WJ.
    J Clin Virol; 2007 Feb 15; 38(2):149-52. PubMed ID: 17196876
    [Abstract] [Full Text] [Related]

  • 33. Immune response after influenza vaccination in children with cancer.
    Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T.
    Pediatr Blood Cancer; 2005 Nov 15; 45(6):831-7. PubMed ID: 16007602
    [Abstract] [Full Text] [Related]

  • 34. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E, Thraenhart O, Werner J, Höher PG.
    Med Klin; 1980 Oct 10; 75(21):755-8. PubMed ID: 7453623
    [Abstract] [Full Text] [Related]

  • 35. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, Bouvier N, Kemble G, Greenberg HB, Lewis DB, Arvin AM, Dekker CL.
    Pediatr Infect Dis J; 2007 Feb 10; 26(2):107-15. PubMed ID: 17259871
    [Abstract] [Full Text] [Related]

  • 36. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 10; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 37. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R, Ikonen N, Santanen R, Haanpää M, Visakorpi R, Jäppinen P, Valle M.
    J Med Virol; 2001 Nov 10; 65(3):584-9. PubMed ID: 11596097
    [Abstract] [Full Text] [Related]

  • 38. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M.
    J Infect Dis; 2000 Mar 10; 181(3):1133-7. PubMed ID: 10720541
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R.
    Virus Res; 2004 Jul 10; 103(1-2):163-71. PubMed ID: 15163505
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K, Kumihashi H, Nerome R, Hiromoto Y, Yokota Y, Ueda R, Omoe K, Chiba M.
    Dev Biol Stand; 1999 Jul 10; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.